FOTIVDA

This brand name is authorized in Austria, Estonia, Spain, Finland, Croatia, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom

Active ingredients

The drug FOTIVDA contains one active pharmaceutical ingredient (API):

1 Tivozanib UNII 172030934T - TIVOZANIB

Tivozanib potently and selectively blocks all 3 Vascular Endothelial Growth Factor receptors (VEGFR) and has been shown to block various VEGF-induced biochemical and biologic responses in vitro. By blocking VEGF-induced VEGFR activation, tivozanib inhibits angiogenesis and vascular permeability in tumour tissues, leading to inhibition of tumour growth in vivo. Read about Tivozanib

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FOTIVDA Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EK03		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
Discover more medicines within L01EK03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1752544, 1752555
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171215001, 1171215002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 077037, 160840
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 350405, 357358
Country: IE	Health Products Regulatory Authority	Identifier(s): 88824, 88825
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1083794, 1083795
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 149497, 149500
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20166, 20190
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100400587, 100400601
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66271001, W66272001